A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse
Clinical trial NCT07223840 · RECRUITING
Trial details
- NCT number
- NCT07223840
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-03
- Primary completion
- 2027-02-01
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.